Rucosopasem was safe and well tolerated
Early indications of anti-cancer activity and pulmonary function preservation
Enrollment ongoing in the randomized, double-blinded, placebo-controlled Phase 2 stage of this trial
Read more at globenewswire.comAll information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
Rucosopasem was safe and well tolerated
Early indications of anti-cancer activity and pulmonary function preservation
Enrollment ongoing in the randomized, double-blinded, placebo-controlled Phase 2 stage of this trial
Read more at globenewswire.com| Symbol | Last | Chg | %Chg |
|---|---|---|---|
| GRTX | 0.0225 | -0.0003 | -1.32% |
| Galera Therapeutics Inc | |||